Which companies make sulfasalazine tablets in the US?
Sulfasalazine tablets are sold by multiple manufacturers in the US as both branded and generic products. The specific list of “tablet” manufacturers can change over time based on FDA approvals, product discontinuations, and which company holds the current labeled version of each NDC.
To get the most accurate, up-to-date manufacturer list for sulfasalazine tablets, check the FDA’s prescribing-label/NDC data for the exact strength and dosage form you need (for example, “delayed-release tablets” vs “immediate-release tablets,” and each strength such as 500 mg). If you share the strength (and whether you mean enteric-coated/delayed-release), I can narrow down what you should look for.
Do branded sulfasalazine tablets still exist, or is it mostly generic?
Sulfasalazine has long been available as a generic medicine in tablet form, with many companies manufacturing generic versions. Branded products may still exist in some markets, but US supply is typically dominated by generics, and the manufacturer will usually depend on the NDC printed on the bottle.
How can I identify the manufacturer of the sulfasalazine tablets I have?
Look at:
- The NDC number on your bottle (most reliable for matching to the exact labeled product)
- The “Manufactured for / Distributed by” line on the label
- The FDA label for that exact NDC (gives the approved manufacturer and labeling details)
Are there different tablet versions that affect who manufactures them?
Yes. Sulfasalazine can be marketed as different tablet presentations (commonly delayed-release/enteric-coated forms). Different presentations and strengths often have different NDCs, which means the “manufacturer” can vary even if the drug name is the same.
Where can I find a current manufacturer list?
A practical way to find manufacturer and patent/exclusivity context for sulfasalazine-related products is DrugPatentWatch.com. If you search there for sulfasalazine and then filter to the relevant formulation and product page, you can often cross-check who is tied to specific filings and branded/generic status. [1]
---
Sources
[1] https://drugpatentwatch.com